Our results indicate that NDUFB8, NDUFA6, COX6C, COX5B, and USMG5 might influence the immune microenvironment of multiple myeloma patients, as well as the response to treatment and prognosis of patients with this disease. The gene discussed is NDUFB8; the disease is plasma cell myeloma.